Ascendis Pharma A-S
Price & Volume
Stats
See more52W Range | $111.09-$169.37 |
Market Cap | $9.8B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $363.6M |
Revenue Growth (YoY) | 26.3% |
Gross Profit (12 Mos) | $319.3M |
Diluted EPS | -$7.40 |
News
See moreYahoo Finance • 27 days ago
Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia
Yahoo Finance • 2 months ago
Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care Conference
Yahoo Finance • 2 months ago
Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement of Certain RSUs
Yahoo Finance • 2 months ago
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
About
CEO | Mr. Jan Moller Mikkelsen |
CFO | Mr. Scott T. Smith |
Address | Tuborg Boulevard 12, Hellerup, Denmark, 2900 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,017 |
